Organizational Chart of Ultragenyx
Decision makers at Ultragenyx by function
General management
-
CIO & Senior Vice President VPd@ultragenyx.comGet the verified email
-
Chief of Staff and Senior Vice President, Head of Program and Portfolio Management VPa@ultragenyx.comGet the verified email
Human resources
-
Executive Vice President & Chief Human Resources Officer VPe@ultragenyx.comGet the verified email
Other functions
-
Chief Medical Officer and Executive Vice President VPe@ultragenyx.comGet the verified email
-
EVP Translational Sciences, Chief Quality Operations Officer VPj@ultragenyx.comGet the verified email
Decision makers at Ultragenyx
Funding and news at Ultragenyx
Funding
| Last round | Other · $400M |
|---|---|
| Total funding | $1.6B (8 rounds) |
Latest news at Ultragenyx
-
Appointment
New ăąăœă·ăšă€ăăăŁăŹăŻăżăŒ appointed â General management
-
Appointment
New Associate Director, Marketing, Lipidology appointed â Marketing
-
Appointment
New Senior Director, Global Health Economics and Outcomes Research appointed â Research
-
Appointment
New Medical Director appointed â Medical
-
Appointment
New Associate Director, Compensation appointed â Human resources
-
Appointment
New Associate Director appointed â General management
-
Appointment
New Director, Regulatory Project Management appointed â Project management
-
Appointment
New Associate Director Regulatory Affairs Emea appointed â Legal
-
Appointment
New Associate Director Global Medical Information appointed â Medical
-
Appointment
New Associate Director - Process Development appointed â Project management
-
Appointment
New Executive Director Marketing and Sales appointed â Marketing
-
Appointment
New Director, Statistical Programming appointed â Research
-
Appointment
New Director Medical Affairs appointed â Medical
-
Appointment
New Associate Director Quality Assurance appointed â General management
-
Appointment
New Associate Director of Biostatistics appointed â Research
Team Structure headcount by department
How to prospect Ultragenyx's departments
Medical
This is where the company's largest headcount sits (241 people). Time with patients is the priority: position your solution as a way to give hours back to care.
Research
The company's second-largest department (207 people). Researchers respond to substance: reference publications, benchmarks or datasets relevant to their field.
Other
This department counts 191 people. A cross-functional team where use cases vary: qualify the actual roles before tailoring your pitch.
Operations
152 people work in this department. Operations leaders live in the concrete: a pilot scoped on one process will convince more than a demo.
General Management
A team of 108 people. General management thinks in strategic priorities: link your value proposition to one of theirs or you will not get a reply.
Project Management
This department counts 76 people. Deadlines and cross-team coordination are the daily battle: position yourself on predictability and visibility.
FAQ Ultragenyx
Who runs Ultragenyx?
The highest-ranking leadership role identified at Ultragenyx is âPartnerâ, based on public data updated 25 Oct 2026.
How many decision makers does Ultragenyx have?
407 decision makers identified, including 6 at executive level.
How do I contact a decision maker at Ultragenyx?
Verified emails and phone numbers are available in Zeliq, with free credits at sign-up.
Companies similar to Ultragenyx
-
Biomarin Pharmaceutical Inc. Biotechnology Research 1001-5000 United States
-
Alnylam Pharmaceuticals Biotechnology Research 1001-5000 United States
-
10X Genomics Biotechnology Research 1001-5000 United States
-
Cepheid Biotechnology Research 1001-5000 United States
-
Revvity Biotechnology Research 1001-5000 United States
More companies to explore
Biotechnology Research · United States
About Ultragenyx
Ultragenyx is a business specialised in Biotechnology Research, operating from United States. The company was founded in 2010 and has a workforce of roughly 5,000 people. As part of the broader Professional Services sector, Ultragenyx operates specifically in the Biotechnology Research segment. Ultragenyx sells primarily to other businesses (B2B) rather than to end consumers. To date, Ultragenyx has completed 8 funding rounds totalling $1.6B. Annual revenue is estimated at around $717M. The data below (industry, headcount, location and business signals) helps sales teams qualify Ultragenyx and pinpoint the right decision makers from the first touchpoint.
Activity & Market
Ultragenyx operates in the Biotechnology Research segment, part of the broader Professional Services sector. As a B2B company, Ultragenyx primarily serves business clients and professional organisations. In terms of structure, it is registered as âPublic companyâ.